Review



control strain e coli atcc 25922  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC control strain e coli atcc 25922
    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. <t>Escherichia</t> <t>coli</t> EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Control Strain E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 55114 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control strain e coli atcc 25922/product/ATCC
    Average 99 stars, based on 55114 article reviews
    control strain e coli atcc 25922 - by Bioz Stars, 2026-04
    99/100 stars

    Images

    1) Product Images from "The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus"

    Article Title: The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus

    Journal: Comparative Immunology Reports

    doi: 10.1016/j.cirep.2025.200266

    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. Escherichia coli EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Figure Legend Snippet: EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. Escherichia coli EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.

    Techniques Used:

    Biofilm Formation of Vibrio isolates and E. coli . Quantitative comparison of biofilm formation among Vibrio isolates and E. coli after 24 h incubation. Biofilm biomass was determined by crystal violet staining and measurement of OD₆₀₀. V. vulnificus MO6 and V. parahaemolyticus NY477 exhibited the highest biofilm-forming capacities.
    Figure Legend Snippet: Biofilm Formation of Vibrio isolates and E. coli . Quantitative comparison of biofilm formation among Vibrio isolates and E. coli after 24 h incubation. Biofilm biomass was determined by crystal violet staining and measurement of OD₆₀₀. V. vulnificus MO6 and V. parahaemolyticus NY477 exhibited the highest biofilm-forming capacities.

    Techniques Used: Comparison, Incubation, Staining



    Similar Products

    99
    ATCC control strain e coli atcc 25922
    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. <t>Escherichia</t> <t>coli</t> EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Control Strain E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control strain e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    control strain e coli atcc 25922 - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    ATCC quality control strain e coli atcc 25922
    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. <t>Escherichia</t> <t>coli</t> EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Quality Control Strain E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/quality control strain e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    quality control strain e coli atcc 25922 - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    ATCC quality control 155 strain e coli atcc 25922
    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. <t>Escherichia</t> <t>coli</t> EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.
    Quality Control 155 Strain E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/quality control 155 strain e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    quality control 155 strain e coli atcc 25922 - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    ATCC quality control strains e coli atcc 25922
    Antimicrobial susceptibility profiles and efficacy of TE-CuONPs against MDR bacterial pathogens. a Inhibition zone diameters for four MDR bacterial strains against conventional antibiotics b - e Disk diffusion assays for E. faecalis , S. aureus , <t>E.</t> <t>coli</t> , and P. aeruginosa (disk positions: 1 = tetracycline, 2 = ampicillin, 3 = norfloxacin, 4 = gentamicin), confirming MDR phenotypes with gentamicin susceptibility only. f Comparative analysis showing TE-CuONPs activity (17.5–18.5 mm) significantly exceeds TE alone (5.5–8.5 mm, p < 0.05) and approaches gentamicin efficacy (20.0–25.0 mm). g MIC and MBC values demonstrating bactericidal activity of TE-CuONPs (MBC/MIC ≤ 0.58) against S. aureus , P. aeruginosa , and E. coli , with bacteriostatic response for E. faecalis (MBC/MIC > 1.05). h Schematic proposal for antimicrobial mechanisms. Different letters indicate statistical significance ( p < 0.05, ANOVA/Tukey). TE-CuONPs exhibit multimechanistic antibacterial activity through ROS generation, membrane disruption, and cellular interference
    Quality Control Strains E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/quality control strains e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    quality control strains e coli atcc 25922 - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    ATCC reference quality control strains e coli atcc 25922
    Antimicrobial susceptibility profiles and efficacy of TE-CuONPs against MDR bacterial pathogens. a Inhibition zone diameters for four MDR bacterial strains against conventional antibiotics b - e Disk diffusion assays for E. faecalis , S. aureus , <t>E.</t> <t>coli</t> , and P. aeruginosa (disk positions: 1 = tetracycline, 2 = ampicillin, 3 = norfloxacin, 4 = gentamicin), confirming MDR phenotypes with gentamicin susceptibility only. f Comparative analysis showing TE-CuONPs activity (17.5–18.5 mm) significantly exceeds TE alone (5.5–8.5 mm, p < 0.05) and approaches gentamicin efficacy (20.0–25.0 mm). g MIC and MBC values demonstrating bactericidal activity of TE-CuONPs (MBC/MIC ≤ 0.58) against S. aureus , P. aeruginosa , and E. coli , with bacteriostatic response for E. faecalis (MBC/MIC > 1.05). h Schematic proposal for antimicrobial mechanisms. Different letters indicate statistical significance ( p < 0.05, ANOVA/Tukey). TE-CuONPs exhibit multimechanistic antibacterial activity through ROS generation, membrane disruption, and cellular interference
    Reference Quality Control Strains E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference quality control strains e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    reference quality control strains e coli atcc 25922 - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    Image Search Results


    EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. Escherichia coli EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.

    Journal: Comparative Immunology Reports

    Article Title: The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus

    doi: 10.1016/j.cirep.2025.200266

    Figure Lengend Snippet: EC 50 results for Vibrio strains against GATR-3, LL-37-NH 2 , and Mastoparan-AF-NH 2 peptides. Vibrio vulnificus MO6 EC 50 results against A. GATR-3, B. LL-37-NH 2 , and C. Mastoparan-AF-NH 2 peptides. Vibrio vulnificus JY1701 EC 50 results against D. GATR-3, E. LL-37-NH 2 , and F. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus NY477 EC 50 results against G. GATR-3, H. LL-37-NH 2 , and I. Mastoparan-AF-NH 2 peptides. Vibrio parahaemolyticus SAK11 EC 50 results against J. GATR-3, K. LL-37-NH 2 , and L. Mastoparan-AF-NH 2 peptides. Escherichia coli EC 50 results against M. GATR-3, N. LL-37-NH 2 , and O. Mastoparan-AF-NH 2 peptides.

    Article Snippet: Against the control strain E. coli ATCC 25922, GATR-3 was extremely potent, with an EC50 of 4.44 × 10−5 μM (1.27 × 10−4 μg/mL), confirming its broad-spectrum and potent efficacy.

    Techniques:

    Biofilm Formation of Vibrio isolates and E. coli . Quantitative comparison of biofilm formation among Vibrio isolates and E. coli after 24 h incubation. Biofilm biomass was determined by crystal violet staining and measurement of OD₆₀₀. V. vulnificus MO6 and V. parahaemolyticus NY477 exhibited the highest biofilm-forming capacities.

    Journal: Comparative Immunology Reports

    Article Title: The synthetic peptide GATR-3 shows significant antibacterial and biofilm-inhibition activity against shellfish- and oyster-associated bacteria Vibrio vulnificus and Vibrio parahaemolyticus

    doi: 10.1016/j.cirep.2025.200266

    Figure Lengend Snippet: Biofilm Formation of Vibrio isolates and E. coli . Quantitative comparison of biofilm formation among Vibrio isolates and E. coli after 24 h incubation. Biofilm biomass was determined by crystal violet staining and measurement of OD₆₀₀. V. vulnificus MO6 and V. parahaemolyticus NY477 exhibited the highest biofilm-forming capacities.

    Article Snippet: Against the control strain E. coli ATCC 25922, GATR-3 was extremely potent, with an EC50 of 4.44 × 10−5 μM (1.27 × 10−4 μg/mL), confirming its broad-spectrum and potent efficacy.

    Techniques: Comparison, Incubation, Staining

    Antimicrobial susceptibility profiles and efficacy of TE-CuONPs against MDR bacterial pathogens. a Inhibition zone diameters for four MDR bacterial strains against conventional antibiotics b - e Disk diffusion assays for E. faecalis , S. aureus , E. coli , and P. aeruginosa (disk positions: 1 = tetracycline, 2 = ampicillin, 3 = norfloxacin, 4 = gentamicin), confirming MDR phenotypes with gentamicin susceptibility only. f Comparative analysis showing TE-CuONPs activity (17.5–18.5 mm) significantly exceeds TE alone (5.5–8.5 mm, p < 0.05) and approaches gentamicin efficacy (20.0–25.0 mm). g MIC and MBC values demonstrating bactericidal activity of TE-CuONPs (MBC/MIC ≤ 0.58) against S. aureus , P. aeruginosa , and E. coli , with bacteriostatic response for E. faecalis (MBC/MIC > 1.05). h Schematic proposal for antimicrobial mechanisms. Different letters indicate statistical significance ( p < 0.05, ANOVA/Tukey). TE-CuONPs exhibit multimechanistic antibacterial activity through ROS generation, membrane disruption, and cellular interference

    Journal: Bioresources and Bioprocessing

    Article Title: Box-Behnken optimized copper oxide nanoparticles from Thymus vulgaris potentiate efficacy against multidrug-resistant bacterial pathogens and exhibit anticancer activity

    doi: 10.1186/s40643-026-01008-5

    Figure Lengend Snippet: Antimicrobial susceptibility profiles and efficacy of TE-CuONPs against MDR bacterial pathogens. a Inhibition zone diameters for four MDR bacterial strains against conventional antibiotics b - e Disk diffusion assays for E. faecalis , S. aureus , E. coli , and P. aeruginosa (disk positions: 1 = tetracycline, 2 = ampicillin, 3 = norfloxacin, 4 = gentamicin), confirming MDR phenotypes with gentamicin susceptibility only. f Comparative analysis showing TE-CuONPs activity (17.5–18.5 mm) significantly exceeds TE alone (5.5–8.5 mm, p < 0.05) and approaches gentamicin efficacy (20.0–25.0 mm). g MIC and MBC values demonstrating bactericidal activity of TE-CuONPs (MBC/MIC ≤ 0.58) against S. aureus , P. aeruginosa , and E. coli , with bacteriostatic response for E. faecalis (MBC/MIC > 1.05). h Schematic proposal for antimicrobial mechanisms. Different letters indicate statistical significance ( p < 0.05, ANOVA/Tukey). TE-CuONPs exhibit multimechanistic antibacterial activity through ROS generation, membrane disruption, and cellular interference

    Article Snippet: Quality control strains - E. coli ATCC 25922, S. aureus ATCC 25923, and P. aeruginosa ATCC 27853—were included in each experimental run to ensure test reliability.

    Techniques: Inhibition, Diffusion-based Assay, Activity Assay, Membrane, Disruption